Owlstone Medical

We are delighted to announce that we have secured $6.5 million of funding from the Bill & Melinda Gates Foundation to develop breath-based diagnostics for infectious diseases. Breath contains many potentially informative compounds that can be used for infectious disease diagnosis and monitoring, and the collection of breath has many unique advantages. Exhaled breath can be collected completely non-invasively and can be developed into portable devices that are easy to use. Through this partnership, we aim to identify non-invasive breath biomarkers of key diseases that disproportionately affect the developing world. We will then use this knowledge to build low-cost devices that can be used to reduce the burden of illness in resource-constrained environments. We are so thankful for the opportunity and are excited to get going with this project and work towards our mission of saving 100,000 lives! https://ow.ly/f9a750RmYvz

This week Roxy Toma is taking on our one minute challenge! As part of the Human Resources department, Roxy helps employees grow and develop - both personally and professionally so that we can achieve our company goals. 🙋♂️ Discover opportunities here at Owlstone by heading over to our careers page: https://ow.ly/Xz7G50SxU41 #PersonalGrowth #HR #science #team #learning

Have you read our recent paper that was published in Metabolomics, titled 'Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform'?🌬️ 📰 Our paper critically examines recent papers that have progressed breath research across different disease areas, including respiratory, infectious, and liver diseases. Check out our video below which summarizes the findings of our paper: https://ow.ly/NgrA50SE7LR Let us know what you think!👏 #breathanalysis #metabolomics #biomarker

🚨 Inflammation is involved in the pathology of many disease conditions. For example, inflammation can be seen in respiratory diseases such as asthma and can provide disease biomarkers. Exhaled breath offers a roster of potential biomarkers arising from pathways in the body that may be disrupted by inflammation in respiratory diseases. 🌬️ 📑 Our ‘Inflammation Hub’ provides a library of useful resources about the role of inflammation in many different diseases and highlights how breath analysis can be used to collect and analyze biomarkers of inflammation. Head over to our hub to find out more👇: https://ow.ly/GW8e50Sy3RR #inflammation #biomarkers #breathanalysis

🌬️Imagine being able to determine your state of health from just a breath of air. Research is revealing the immense potential for volatile organic compounds (VOCs) from exhaled breath to serve as valuable biomarkers of health in a wide range of disease areas. How do breath biopsies fare against current methods? There are many benefits of using biomarkers in breath compared to other biomarker sampling techniques: 1. The non-invasiveness of breath sampling is pain and risk free. It can therefore be easily scaled to large populations and used even in high-risk groups. 2. Exhaled breath is a continuously produced waste product, compared to sampling methods like blood and urine samples where only a small amount can be collected at infrequent intervals. 3. Breath biomarkers are normal products of metabolism, which could be altered when the earliest effects of disease onset are present. 4. Many VOCs in the breath arise from the blood, which can reflect the health of the entire body. 5. Breath biopsies do not have the same costs as tissue biopsies, which are highly invasive and could miss regions of pathology if patchy. 6. Non-medical professionals can perform breath sampling as only basic training is required. 7. Breath sampling minimises pain, lifestyle impact, and logistical challenges, potentially improving patient recruitment and retention for clinical trials. Considering this, it is exciting to see the future applications of breath biopsies in the near future. Read more about the benefits of breath biopsies in our blog: https://ow.ly/Et1h50SFr0o

🌟 Exciting Insights into Gut Health! 🌟 Discover how different diets impact SCFA (short-chain fatty acids) production, essential for gut health. High-fiber diets boost beneficial SCFAs, while high-fat, low-fiber diets can disrupt this balance. Ever wondered how fasting might alter gut microbiota and SCFA levels in your breath? Or how a high-fiber diet or complex carbohydrates affect SCFA production? How does it relate to diseases? 🔎 If you want to know more, check out this great article on SCFAs and disease from Owlstone Medical https://lnkd.in/eCWYyqFW

🔎Discover lower-cost, at-home monitoring of microbiome biomarkers in clinical trials through our recent webinar session. Our experts introduce the OMED Health Breath Analyzer, an innovative tool for monitoring microbiome metabolites at home. This compact device provides immediate hydrogen and methane readings to your phone via Bluetooth. Key Points from the Webinar: ▶️ Understanding Hydrogen & Methane in GI Diseases ▶️ Insights on Hydrogen & Methane in Various Disease Contexts ▶️ Advanced Technology of the OMED Device ▶️ Expanding the On-Breath VOCs Atlas Don't miss the opportunity to gain groundbreaking insights! Watch the webinar by clicking on the provided link. 🔗 📢https://ow.ly/eVaK50SFa3f

Are you interested in using breath analysis for infectious disease research? You may have missed the release of our document, ‘Breath Analysis and Infectious Disease: Owlstone Medical’s 101’. It contains everything you need to know about why we use breath, what data we have, and how we can help you incorporate breath analysis into your research. Watch our short video below to learn more. You can download the document for free here: https://ow.ly/ihyA50R9rlA #InfectiousDisease #VOCs #BiomarkerResearch

🌐 Asthma is a chronic inflammatory condition affecting millions of people worldwide. Breath contains volatile organic compounds (VOCs), many of which are produced in the respiratory tract due to processes such as lipid peroxidation, that could serve as new biomarkers for asthma. 🌬️ VOCs can also be produced by the immunological mechanisms that underpin asthma pathophysiology and could be used as biomarkers to stratify asthma patients. We performed a literature review to collate which VOCs in breath are associated with asthma and collated this with our internal VOC Atlas data. 📊 You can read about what compounds were identified in our case study: https://ow.ly/AfXr50ScRRp #asthma #breathanalysis